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Abstract
We present an Expectation-Maximization (EM) Regularized Deep Learning (EM-
ReDL) model for the weakly supervised tumor segmentation. The proposed frame-
work was tailored to glioblastoma, a type of malignant tumor characterized by
its diffuse infiltration into the surrounding brain tissue, which poses significant
challenge to treatment target and tumor burden estimation based on conventional
structural MRI. Although physiological MRI can provide more specific information
regarding tumor infiltration, the relatively low resolution hinders a precise full
annotation. This has motivated us to develop a weakly supervised deep learning
solution that exploits the partial labelled tumor regions.
EMReDL contains two components: a physiological prior prediction model and
EM-regularized segmentation model. The physiological prior prediction model
exploits the physiological MRI by training a classifier to generate a physiological
prior map. This map was passed to the segmentation model for regularization
using the EM algorithm. We evaluated the model on a glioblastoma dataset with
the available pre-operative multiparametric MRI and recurrence MRI. EMReDL
was shown to effectively segment the infiltrated tumor from the partially labelled
region of potential infiltration. The segmented core and infiltrated tumor showed
high consistency with the tumor burden labelled by experts. The performance
comparison showed that EMReDL achieved higher accuracy than published state-



























aggressive features than other partial labelled region. The proposed model can
be generalized to other segmentation tasks with partial labels, with the CNN
architecture flexible in the framework.
1 Introduction
Glioblastoma is the most common malignant primary brain tumor, characterized by poor outcomes
(Wen et al., 2020). The first-line treatment includes maximal safe resection followed by chemoradio-
therapy (Stupp et al., 2005), which requires an accurate tumor delineation to enhance the treatment
efficacy and reduce the neurological deficits of patients (Mazzara et al., 2004; Stupp et al., 2005). As
the manual delineation is often subjective and laborious, an automated tumor segmentation model is
crucial in aiding clinical practice. Currently, Magnetic Resonance Imaging (MRI) is the mainstay
for diagnosis, treatment planning, and disease monitoring of glioblastoma (Weller et al., 2014, 2017;
Wen et al., 2020) . It however remains a challenge to accurately segment the glioblastoma based on
MRI (Wadhwa et al., 2019), mainly due to several reasons. Firstly, glioblastoma is characterized by
diffuse infiltration into the surrounding brain, leading to a poorly demarcated tumor margin. Secondly,
glioblastoma is highly heterogeneous with regard to the tumor location, morphology and intensity
values. Thirdly, glioblastoma may demonstrate similar appearance with neurodegenerative or white
matter pathologies. All of the above may pose significant challenges to a robust segmentation model.
Incorporating multiple MRI modalities is considered beneficial for tumor segmentation (Ghaffari
et al., 2020). Clinically, the most commonly used sequences include T1-weighted, T2-weighted,
post-contrast T1-weighted (T1C), and fluid attenuation inversion recovery (FLAIR) sequences. A
multimodal brain tumor image segmentation (BraTS) challenge represents the collective efforts
to develop segmentation models using a large glioblastoma dataset with multiple MRI sequences
available (Bakas et al., 2018). A wide spectrum of models has since been proposed with dramatic
success in performance (Ghaffari et al., 2020). Among these models, deep learning shows unique
advantages in using multiple MRI sequences for tumor segmentation, compared to the traditional
methods of using hand-crafted features. However, the BraTS dataset only includes the most widely
used structural sequences, which was shown to be prone to the low specificity in targeting actual
tumor infiltration (Verburg et al., 2020). Particularly, for the non-enhancing lesion beyond the
contrast-enhancing margin, it remains challenging to differentiate the infiltrated tumor from edema,
even combining all the structural sequences (Verburg et al., 2020). An effective imaging model with
higher specificity in segmenting the infiltrated tumor is of crucial value for clinical decision making.
An increasing amount of literature provides evidence that physiological MRI can facilitate the
characterization of tumor infiltration (Li et al., 2019a; Yan et al., 2019). In particular, diffusion
and perfusion MRI can identify the infiltrated tumor beyond the contrast enhancement by offering
parametric measures describing tumor physiology, which may complement the non-specificity of the
structural sequences. Specifically, The diffusion MRI is the only imaging method of describing brain
microstructure by measuring water molecule mobility (Jellison et al., 2004), which can detect the
subtle infiltration (Li et al., 2019b), characterize tumor invasiveness (Li et al., 2019d) and predict
tumor progression (Yan et al., 2020). On the other hand, as a widely used perfusion technique,
dynamic susceptibility contrast (DSC) imaging can derive the relative cerebral blood volume (rCBV),
mean transit time (MTT) and relative cerebral blood flow (rCBF), reflecting the aberrant tumor vascu-
larization (Lupo et al., 2005). Therefore, integrating physiological MRI into the tumor segmentation
model shows potential to more accurately identify tumor infiltration.
Here we proposed a deep learning model to automatically segment the core and infiltrated tumor based
on both structural and physiological multiparametric MRI. We hypothesized that the physiological
MRI information of the core tumor could be used to guide the deep learning model to segment the
infiltrated tumor beyond the core tumor. In the next section, we summarize the related work of tumor
segmentation, including both supervised and weakly supervised models.
2 Related work
Tumor segmentation is an active research field with a growing number of models proposed. These
models can be generally classified into generative or discriminative models (Ghaffari et al., 2020).
Typically, generative models rely on the prior knowledge of the voxel distributions of the brain
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tissue, which is derived from the probabilistic atlas (Prastawa et al., 2004), whereas the discriminative
models rely on the extracted image features that could be mapped to the classification labels. In
general, discriminative models show superior performance than generative models. Most successful
discriminative approaches in the BraTS challenge (Menze et al., 2015) are based on fully supervised
convolutional neural networks (CNN).
In BraTS 2014, a CNN-based model was firstly introduced. The top-ranked algorithm employed a
3D CNN model trained on small image patches, which consisted of four convolutional layers with six
filters in the last layer corresponding to six labels (Urban et al., 2014). In BraTs 2015, a 2D CNN
model with a cascaded architecture was proposed. Two parallel CNNs were employed to extract
local and global features which were then concatenated and fed into a fully connected layer for
classification (Dutil et al., 2015). In BraTS 2016, DeepMedic, a 3D CNN model of eleven layers with
residual connections was proposed. Two pathways were employed to process the inputs in parallel,
to increase the receptive field of the classification layer (Kamnitsas et al., 2016). In BraTS 2017,
the Ensembles of Multiple Models and Architectures (EMMA) separately trained several models
(DeepMedics, 3D FCN, and 3D U-net) using different optimization approaches, while the output
was defined as the average to reduce bias from individual models (Kamnitsas et al., 2017). The
top-ranked model in BraTS 2018 proposed an asymmetric U-net architecture, where an additional
variational auto-encoder branch was added to the shared encoder, providing additional regularization
(Myronenko, 2018; Warrington et al., 2020). In BraTS 2019, the top-ranked model proposed a
two-stage cascaded U-Net (Jiang et al., 2019). The first stage used a U-Net variant for preliminary
prediction, whereas the second stage concatenated the preliminary prediction map with the original
input images to refine the prediction.
In summary, the above top-ranked models from the BraTS depict the advantages of CNN-based
segmentation model, which highlights the capacity of feature extraction of CNN. Further, to enhance
the model performance or reduce the computational cost, various techniques were employed to
improve the backbone CNN by a series of procedures, e.g., increasing network depth or width,
optimizing the loss function, increasing receptive fields, or adopting an ensemble model. For more
details of the BraTS models, please refer to (Bakas et al., 2018; Ghaffari et al., 2020). All these state-
of-the-art models heavily rely on the full classification labels to train a model that could approximate
the accuracy of experts. The infiltrative nature of glioblastoma, however, poses significant challenges
to accurate delineation of the interface between tumor and healthy tissue. Although the binary
contrast-enhancement provided a reference for “core tumor”, the surrounding non-enhancing region,
regarded as the edema in BraTS labels, has established as diffusively infiltrated with tumor.
As outlined in the previous section, multiparametric MRI allows more accurate identification of the
non-enhancing infiltrated tumor. Nevertheless, the low resolution of physiological MRI hinders the
precise annotation based on these images. A full annotation based on physiological MRI therefore is
prone to the subjective errors, even by experienced clinical experts. As a result, those models with
high reliance on the full labels may not be suitable for segmented the infiltrated tumor.
Other studies investigated the feasibility of delineating tumor infiltration based on the weak labels of
cancerous and healthy tissues. (Akbari et al., 2016) proposed a tumor infiltration inference model
using the physiological and structural MRI (Akbari et al., 2016). Two types of weak labels were used,
i.e., one scribble immediately adjacent to the enhancing tumor and another scribble near the distal
margin of the edema. These two scribble regions, representing the tissue near and far from the core
tumor respectively, were hypothesized to correspondingly have higher and lower tumor infiltration.
The classifier was trained based on the weak labels using the support vector machine (SVM) which
yielded a voxelwise infiltration probability. The model achieved excellent performance and was
subsequently validated by another cohort and the tumor recurrence on the follow-up scans.
Although in relatively small sample size, this study underpinned the advantage of physiological MRI
in identifying tumor infiltration and supported the feasibility of weakly supervised learning models
to tackle the challenge of lacking precise full annotations. The proposed model, however, ignored
the spatial continuity of tumor infiltration. The CNN model could empower the weakly supervised
learning model (Chan et al., 2020) by effectively extracting multiparametric MRI features with spatial
information.
Training a weakly supervised CNN model using a partial cross-entropy loss may lead to poor
boundary localization of saliency maps (Zhang et al., 2020). To mitigate this limitation, additional
regularization is often employed. For instance, (Tang et al., 2018)introduced a normalized cut loss as
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a regularizer with a partial cross-entropy loss. (Kervadec et al., 2019) introduced a regularization
term constraining the size of the target region that was combined with a partial cross-entropy loss.
(Roth et al., 2019) used the random walker algorithm to generate the pseudo full label from the partial
labels and then constructed the regularized loss by enforcing the CNN outputs to match the pseudo
labels. The results of above studies supported the usefulness of additional regularizers in the weakly
supervised models. Due to the advantages of physiological MRI in detecting tumor infiltration, here
we hypothesized that a regularizer from the physiological MRI could enhance the weakly supervised
model for segmenting the infiltrated tumor by incorporating domain-specific information.
We sought to propose a CNN-based weakly supervised model, in which a regularization term was
constructed by incorporating the prior information obtained from the physiological MRI by an
prediction model through an expectation-maximization (EM) framework. We evaluated the model
validation using tumor recurrence on follow-up scans and MR spectroscopy that non-invasively
measures the metabolic alternation. The remainder of this paper is organized as follows: Section
3 will describe the overall study design, main components of the proposed framework and the
performance evaluation of the model. Section 4 gives details of the dataset and the implementation of




Consider the multiparametric MRI from N (patients) training samples X = {X1, X2, · · · , XN},
including both structural sequences (T1-weighted, T2-weighted, T1C and FLAIR) and physiological
sequences (diffusion and perfusion MRI), denoted as Xs and Xp, respectively. From a clinical
perspective, three regions of interest (ROI) can be delineated (Figure 1):
◦ ROI1: core tumor, which is the contrast-enhancing tumor region on T1C images and the
surgery target for clinical practice;
◦ ROI2: potential infiltrated region, which is the hyperintensities in FLAIR images outside of
ROI1. We are specifically interested in this region as it represents the clinically extendable
treatment target;
◦ ROI3: normal-appearing region on both T1C and FLAIR sequences.
All MRI sequences have been co-registered. The voxel labels can be classified into observed labels
yo and unobserved labels yu. A voxel label y is a value either 0 or 1, and yo indicates the labels
of ROI1 and ROI3, where y = 1 indicates a confirmed tumor voxel and y = 0 represents a voxel
from the normal-appearing brain region. The yu indicates label of ROI2. Given X, we aimed to
simultaneously segment the core tumor (ROI1) and the peritumoral infiltrated tumor in ROI2.
3.2 Overview of the proposed method
Our goal was to segment the core and infiltrated tumor using the model trained by the existing MRI
data X and its corresponding observed labels yo. For the standard supervised CNN models, full
training labels are necessary to be used as the ‘ground-truth’ to train the weights θ of the CNN. In our
proposed application, however, as it is not possible to obtain a full annotation for the unobserved labels
yu, which renders a supervised CNN training inappropriate. In this paper, we cast the underlying
problem into a weakly supervised learning problem by leveraging the EM algorithm, which can
recursively estimate both the unknown parameters (M-step) and the unobserved labels (E-step) in
the proposed segmentation problem. The problem can now be treated as a CNN model training task
using partial labels.
As shown in Figure 1, the proposed method consists of two main components: physiological prior
prediction model (left panel) and EM-regularized segmentation model (right panel). The left panel
takes in physiological MRI information to train a classifier and generate voxelwise estimate of the
unobserved labels in ROI2. The estimated label information is then passed into the right panel to
improve the prediction performance of the segmentation model. Specifically, the label information is
used to initialize ROI2 labels in the CNN model training in M-step, and is also integrated into E-step
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Figure 1: Diagram of the proposed method. The left panel describes the physiological prior prediction
process. A classifier is trained to generate physiological prior map. The right panel depicts the EM
regularized CNN model training process. The Expectation-Maximization (EM) framework is used to
fulfill and optimize the weakly supervised model, where a CNN model is trained in the M-step and
the distribution of unobserved ROI2 are estimated in the E-step. J(θ) is the loss term of CNN model,
and is calculated using scaled summation of both Jreg(θ) and Jsup(θ). The term Jreg(θ) denotes the
regularized loss generated by the conditional distribution computed by Equation (5), and Jsup(θ)
denotes the supervised loss from the observed labels yo.
to recursively update the estimation of the unobserved label yu. The expected outcome of the right
panel is a trained CNN segmentation model that can effectively distinguish the infiltrated tumor from
the non-cancerous abnormalities, e.g., edema.
The pipeline introduced in Figure 1 can be further generalized to other similar segmentation problems
with partially unobserved labels. Both the classifier in the left panel and the CNN segmentation model
in the right panel are flexible to be replaced by other feed-forward deep learning models or CNN
models with architectures other than the ones used in this paper. Given this, we will not explicitly
describe detailed architecture of the CNN models used in the proposed method.
3.3 Physiological prior prediction
As discussed above, physiological MRI is more specific for tumor infiltration but in lower resolu-
tion than structural MRI. Treating physiological MRI and structural MRI equally may not able to
effectively leverage the specific information from physiological MRI. Therefore, a physiological
prior map which incorporates only the information of physiological MRI is generated to describe the
extracted knowledge of ROI2. In particular, we constructed the underpin component to approximate
the unobserved labels yu of ROI2, using a classifier trained by both the physiological MRI Xp and
the observed labels yo.
Since the labels yo in ROI1 and ROI3 only contain binary values 1 and 0, we used a binary classifier
constructed by a fully connected neural network with two hidden layers. The number of hidden
neurons is set equal to the number of input features from Xp. The model produces probabilisitic
prodicton for the distribuion of unoberserved labels yu in ROI2 with predicted value between [0, 1].
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The predicted physiological prior map can then be formulated as pmap(yu|Xp,yo), which was used
in the EM-regularized weakly supervised learning segmentation component.
3.4 Segmentation with EM-regularized weakly supervised learning
In this component, a segmentation model constructed by a typical U-Net CNN architecture is trained
for tumor segmentation. Different from the physiological prior prediction model, the segmentation
model is trained using both physiological MRI Xp and structural MRI Xs. The EM algorithm is
leveraged in this component to estimate the unobserved label yu and recursively optimize both the
model accuracy and label accuracy of the partial labels potential infiltrated region. To perform this
weakly supervised learning segmentation task, we firstly define the likelihood function as:
L(θ) = p(yu,yo|X,θ), (1)
for which the maximum likelihood estimate with respect to the weights θ (of CNN) can be computed




Nevertheless, the integral is often intractable and exact integration over all possible yu values is
challenging.
EM algorithm solves the problem by iteratively estimating the unknown term yu in the expectation
step (E-step) and θ in the maximization step (M-step). See (McLachlan and Krishnan, 2007) for
details of the standard EM algorithm.
In this work, EM performs E-step by defining
Q(θ|θ(t)) = Ep(yu|yo,X,θ(t))[logL(θ)], (3)
=
∫
p(yu|yo,X,θ(t)) log p(yu,yo|X,θ), (4)
where θ(t) denotes the estimated CNN weights in iteration t. Q(θ|θ(t)) computes the expectation
of the log-likelihood of function L(θ) with respect to the conditional distribution p(yu|yo,X,θ(t)),
which can be defined as:
p(yu|yo,X,θ(t)) = γpmap(yu|Xp,yo) + (1− γ)pseg(yu|X,yo,θ(t)). (5)
The former term on the RHS is the physiological prior map generated by the binary classifier and the
latter term is the predicted labels in the current tth iteration of EM. γ denotes a voxelwise coefficient,
which will be used to integrate the physiological prior map and the prediction of segmentation model.




The conditional distribution p(yu|yo,X,θ(t)) can be obtained by the designed CNN model, where
its weight is given by θ(t).
From the perspective of loss function in CNN model training, Equation (6) can also be treated as the
regularization terms to minimize the training loss of the segmentation model in M-step. In practice,
the training loss J(θ) is defined as:
J(θ) = Jsup(θ) + Jreg(θ), (7)
which is a summation of both the supervised loss Jreg(θ) from the fixed observed labels yo and
the regularised loss Jsup(θ) from pseudo labels ŷu calculated using the conditional distribution in
Equation (5).
3.5 Model evaluation
We validated the proposed model using tumor burden, tumor recurrence and MRS. To examine the
usefulness of the regularizer, we compared our model performance with the baseline model which
6
employed the U-net with a partial cross-entropy loss without the additional regularizer from the
physiological prior. We also compared our model with other methodsAkbari et al. (2016); Tang et al.
(2018); Kervadec et al. (2019); Roth et al. (2019).
1) Tumor burden estimation
The finally segmented tumor volume was calculated as the core tumor burden (the delineated tumor
in ROI1) and infiltrated tumor burden (the delineated tumor in ROI2). A linear regression was used
to test the consistency of the segmented volumes from different models with the ground truth. Forthe
core tumor (ROI1), the ground truth was used as the volume of the manual label. For the infiltrated
tumor, the ground truth was used as the volumme of the recurrence within the potential infiltrated
region (ROI2).
2) Tumor burden and recurrence prediction
The finally segmented tumor region was examined in the prediction of complete tumor burden and
tumor recurrence region in the follow-up MRI of 68 patients who received the complete resection,
which is defined clinically as a complete resection of contrast-enhancing tumor (ROI1). The potential
infiltrated region (ROI2) on the pre-operative images was divided into recurrence region Rrecur and
non-recurrence region RCrecur, according to the manual label, where C represents the complementary
operation.
For each patient, the pre-operative contrast-enhancing core tumor (ROI1) on T1C image was denoted
as RCE , therefore the total tumor burden was defined as Rtotal = Rrecur ∪ RCE , whereas the
normal-appearing area Rnormal was defined as RCtotal. The segmented tumor area R̂seg and normal-
appearing area R̂Cseg can be derived automatically by thresholding the tumor infiltration probability
that was finally produced by EMReDL. Finally, The sensitivity and specificity of predicting tumor















After calculating the sensitive and specificity, the optimum threshold T for discriminating predicted
infiltration mask was chosen by maximizing the Youden Index of the ROC curves.
3) Magnetic resonance spectroscopy validation
The metabolic signature was compared for the infiltrated region and non-infiltrated region segmented
by our model in the potential infiltrated region (ROI2). The metabolic measures, including Choline,
N-acetylaspartate (NAA) and Cho/NAA were calculated for the infiltrated region and non-infiltrated
region, respectively. To account for the resolution difference between T2 and MRS space, all co-
registered data were projected to MRS space, according to their coordinates using MATLAB. The
proportion of T2-space tumor pixels occupying each MRS voxel was calculated. Paired t-test was
used to compare the metabolic measures of the infiltration and non-infiltration regions.
4 Experiments
4.1 Data description
This study was approved by the local institutional review board and informed consent was obtained
from all patients. A total of 115 glioblastoma patients was prospectively recruited for maximal safe
resection. Each patient underwent pre-operative multiparametric MRI, using a 3-Tesla MRI system
(Magnetron Trio; Siemens Healthcare, Erlangen, Germany) with a standard 12-channel receive-head
coil. The sequences included T1, T1C, T2, T2-FLAIR, diffusion imaging, DSC and multivoxel 2D
1H-MRS chemical shift imaging.
7
4.2 Image pre-processing
1) Multiparametric MRI processing
Diffusion MRI was processed using the diffusion toolbox (FDT) in FSL v5.0.8 (FMRIB Software
Library, Centre for Functional MRI of the Brain, Oxford, UK). After normalization and eddy current
correction, parametric maps of fractional anisotropy (FA), mean diffusivity (MD), p (isotropy) and q
(anisotropy) were calculated as previously described (Li et al., 2019e,c). DSC was processed using
the NordicICE (NordicNeuroLab, Bergen, Norway), with arterial input function automatically defined
and leakage corrected. The parametric maps of rCBV, MTT and rCBF maps were calculated. The
MRS data were processed using LCModel (Provencher, Oakville, Ontario) as previously described.
All metabolites were calculated as a ratio to creatine (Cr).
2) Image co-registration
All pre-operative parametric maps were co-registered to the T2 space using FSL linear image
registration tool (FLIRT) with an affine transformation. For the co-registration of the recurrence
image to the pre-operative images, the recurrence T1C images were non-linearly co-registered to the
pre-operative T2 images using the Advanced Normalization Tools (ANTs), with the pre-operative
lesion masked out.
3) Image normalization
All MRI from different patients were normalized using the histogram matching method. Specifically,
for each sequence, the image histograms for all patients were calculated, where the histogram closest
to the averaged histogram was determined as the reference and normalized to [0, 1]. Finally, other
image were matched to the reference histogram.
4.3 Labelling of pre-operative and recurrence tumor
Preoperative tumor and recurrence regions were manually delineated on the T1C and FLAIR images
using the 3D slicer v4.6.2 (https://www.slicer.org/). The delineation was independently performed by
a neurosurgeon (XX) and reviewed by a neuroradiologist (XX). Each rater used consistent criteria
in each patient and was blinded to patient outcomes. The contrast-enhancing (CE) core tumor was
defined as the regions within the contrast-enhancing margin on T1C images. The FLAIR ROI was
defined as the hyperintensities on FLAIR images. Finally, the peritumoral ROIs were defined as the
non-enhancing regions outside of contrast-enhancing regions, obtained by a Boolean subtraction of
CE and FLAIR ROIs in MATLAB.
4.4 Treatments
Patient was treated and followed up by the multidisciplinary team (MDT) according to the clinical
guidelines. The extent of resection was assessed according to post-operative MRI within 72 hours.
During the follow up of patients, clinical and radiological data were incorporated according to the
Response Assessment in Neuro-oncology criteria.
4.5 Implementation details
We divided the complete dataset into two sets randomly: 50% as the training set (images of 57
patients) and 50% as the testing set (images of 58 patients). For the training set, 75% of the data was
used for model training and the remaining 25% was used for model validation.
For the training of physiological prior prediction model, the multiparametric MRI feature vector for
of the voxels in the ROI1 and ROI3 were used as the input of the empirical fully connected network.
The model was trained to minimize the losss function. Adam optimizer was applied to train the model
with initial learning rate set to 10−4, and the model was trained for 1000 epochs using mini-batches
of size 5x104. To tackle the class imbalance problem, equal numbers of majority- and minority-class
samples were randomly selected for each mini-batch. Finally, the model with smallest validation
error was adopted.
After the training of the physiological prior prediction model, a physiological prior map with the
tumor infiltration probability was obtained. The EM-regularized weakly supervised segmentation
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model was trained for 200 epochs using Adam optimizer with initial learning rate of 10−4, and mini-
batch size of 8. For the training of the first epoch, the prior infiltration probability was used as the
probabilistic training labels in ROI2, the potential infiltration regions. Afterwards, the probabilistic
training labels were updated for each epoch. The model with lowest validation error was finally
chosen.
5 Results and Discussion
The experiment results showed that the proposed weakly supervised model achieved high accuracy
in segmenting the core and infiltrated tumor area, which could be validated by the tumor burden
estimation, tumor recurrence prediction and identification of invasive areas in MRS. The results are
presented in below.
5.1 Tumor burden estimation
Tumor burden is crucial for patient risk stratification and treatment planning. We calculated the tumor
burden estimated from the different models as the volume of the segmented regions (Table 1). For the
core tumor, the results showed that all CNN models achieved comparable volumes with the grund
truth, highlighting the capacity of CNN in core tumor segmentation. For the infiltrated tumor, our
results showed EMReDL achieved most similar results with the recurrence volume.













Training 45.4±29.4 44.8±29.2 33.7±18.9 45.0±29.2 43.6±27.7 43.4±27.7 44.3±28.7
Testing 48.8±29.7 46.8±29.0 36.4±20.5 46.7±28.8 45.7±27.7 43.8±26 45.0±27.1
Infiltrated
tumor
Training 17.9±16.2 9.4±6.2 31.4±22.1 9.1±5.2 20.9±10.5 16.0±10.8 17.5±17.5
Testing 24.0±19.3 13.2±18 34.8±26.5 12.5±18.4 22.4±15.1 20.2±18.5 24.2±22.4
Unit: cm3; Comparison model 1: SVM. Comparison model 2: Normalized cut loss. Comparison
model 3: Size-constrained loss; Comparison model 4: Random walker regularized loss
We also performed the regression analysis between the tumor burden estimated from the models with
the ground truth (Table 2). The results showed that for the core tumor, all tested models showed
consistency in core tumor burden estimation. However, for the infiltrated tumor, EMReDL achived
better consistency over other tested models.










R 0.998 0.939 0.998 0.989 0.990 0.995
P <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Infiltrated
tumor
R 0.641 0.839 0.549 0.842 0.859 0.978
P <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Comparison model 1: SVM. Comparison model 2: Normalized cut loss. Comparison model 3:
Size-constrained loss; Comparison model 4: Random walker regularized loss
5.2 Recurrence prediction
Firstly, we compared the performance of the baseline model and EMReDL. The ablation experiment
showed that EMReDL achieved superior accuracy in predicting tumor recurrence compared to the
baseline model which employed the U-net with a partial cross-entropy loss. The results suggest
the usefulness of incorporating the additional regularizer constructed from the physiological MRI.
Of note, the baseline model achieved higher higher sensitivity, but lower specificity than EMReDL,
which is mainly due to the much smaller segmentation regions. The quantitative comparison results
of the EMReDL and baseline model are in Table 3.
Figure 2 presents two examples of infiltration area predicted by the EMReDL and baseline model. The
pre-operative structural MRIs, including FLAIR, T1C (Figure 2A,B), recurrence T1C (Figure 2C), and
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Table 3: Comparisons of baseline and EMReDL
EMReDL Baseline
AUC Train 0.971 0.897Test 0.965 0.890
Sensitivity Train 0.906 0.789Test 0.898 0.772





Dice Train 0.849 0.745Test 0.846 0.733
MCC Train 0.823 0.716Test 0.808 0.689
AUC: area under the curve. MCC: Matthews correlation coefficient
physiological MRI including DTI-q, DTI-p, FA, MD, MTT, rCBV and rCBF (Figure 2H-N), as well
as the overlaid labels (red: contrast-enhancing core tumor, ROI1; blue: non-enhancing peritumoral
region, ROI2). The prediction of two models is overlaid on pre-operative (Figure 2D: bassline, Figure
2E: EMReDL) and recurrence (Figure 2F: bassline, Figure 2G: EMReDL) T1C images. Note the
recurrence area is well beyond the contrast-enhancing tumor core on the pre-operative MRI, which
showed high correspondence with the infiltrated area identified by EMReDL. This improvement
could possibly be explained by the tumor invasion area revealed by the physiological MRI shown
underneath. Note the ground truth (the red region) of the complete tumor burden was taken as the
combination of the core tumor and the recurrence tumor, with the assumption that the infiltrated tumor
in the FLAIR is more responsible for the recurrence outside of the core tumor than other regions.
Next, we compared our results of the segmented infiltration area with other weakly-supervised models
proposed in (Akbari et al., 2016; Kervadec et al., 2019; Roth et al., 2019; Tang et al., 2018). The
results (Table 4) showed that all the models with additional loss achieved better accuracy than the
SVM model, suggesting the usefulness of considering the spatial information through CNN in the
prediction. Further, the EMReDL obtained higher accuracy than other weakly supervised models,
which again supports the value of incorporating the physiological information through the separate
physiological prior prediction model from the main segmentation model. As mentioned, physiological
MRI has higher specificity in reflecting tumor biology but lower resolution than structural MRI.
Benefiting from the separately designed model, the physiological information could be effectively
employed and less affected by the structural MRI, which hence could improve the model performance.
In comparison, the pseudo labels generated through the normalized cut loss in (Tang et al., 2018) and
the random walker loss in (Roth et al., 2019) were obtained by treating the structural and physiological
MRI equally, therefore may not effectively leverage the information from physiological MRI.
Figure 3 presents an example with the comparison of different models. Figure 3a-d show the
structural images including T1C, FALIR, T1 and T2. Figure 3e and 3f show the FLAIR abnormality
and contrast-enhancing tumor respectively, while Figure 3g indicates the recurrence regions on the
follow up scans. The physiological MRI, including DTI-q, DTI-p, FA, MD, MTT, rCBV and rCBF,
are shown in Figure 2H-N. Indeed, the EMReDL shows the highest performance, whereas the SVM
model shows lower accuracy than all other models.
Lastly, we compared the performance of the different models in segmenting the infiltrated area in
Table 5. As expected, all models obtained lower performance than segmenting the complete tumor
burden including the core tumor, as we only take the recurrence region as the ground truth, while
some non-recurrence area may also display invasive imaging features in the pretreatment MRI. For
the model comparison, however, EMReDL achieved higher performance than other models, which
may imply the value of the additionally constructed regularizer.
To summarize, the model comparisons may validate the performance of the proposed weakly su-
pervised model. Also, our model showed comparable performance in both training and testing sets,
which could suggest the robustness of the model.
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Figure 2: Two case examples with the segmentation results of baseline model and EMReDL. For
both cases, A: FLAIR, B: T1C, C: recurrence T1C (red: ROI1, contrast-enhancing core tumor; blue:
ROI2, peritumoral non-enhancing region); D-G: model results (red) with the ROI2 (blue) overlaid.
D: baseline result on pre-operative T1C image; E: EMReDL result on pre-operative T1C image;
F: baseline result on recurrence T1C images; G: EMReDL result on recurrence T1C images; H-N:
pre-opearive DTI-q, DTI-p, FA, MD, MTT, rCBV and rCBF images in sequence.









AUC Train 0.764 0.901 0.855 0.923 0.971Test 0.788 0.888 0.866 0.919 0.965
Sensitivity Train 0.757 0.790 0.845 0.838 0.906Test 0.765 0.764 0.824 0.815 0.898
Specificity Train 0.664 0.934 0.799 0.882 0.918Test 0.679 0.930 0.841 0.891 0.916
Youden
index
Train 0.422 0.724 0.644 0.720 0.825
Test 0.444 0.693 0.664 0.706 0.813
Dice Train 0.593 0.749 0.725 0.764 0.849Test 0.621 0.727 0.739 0.755 0.846
MCC Train 0.423 0.722 0.645 0.717 0.823Test 0.444 0.685 0.658 0.697 0.808
AUC: area under the curve. MCC: Matthews correlation coefficient. Comparison model 1: SVM.
Comparison model 2: Normalized cut loss. Comparison model 3: Size-constrained loss; Comparison
model 4: Random walker regularized loss
Figure 3: Case examples of model comparison. Top panel: pre-operative and recurrence images.
a-d: pre-operative T1C, FLAIR, T1Pre, T2 in sequence. e-g: labelled pre-operative FLAIR, T1C,
and recurrence T1C; h-n: pre-operative DTI-q, DTI-p, FA, MD, MTT, rCBV and rCBF images in
sequence. Bottom panel. Model results (red) with the ROI2 (blue) overlaid. The green lines indicate
the ground truth. A-G: segmentation of different models overlaid on pre-operative T1C images. H-N:
segmentation of different models overlaid on recurrence T1C images.
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AUC Train 0.674 0.781 0.680 0.778 0.804 0.915Test 0.707 0.807 0.701 0.807 0.837 0.938
Sensitivity Train 0.463 0.787 0.480 0.771 0.736 0.809Test 0.523 0.801 0.517 0.790 0.779 0.876
Specificity Train 0.868 0.664 0.860 0.676 0.757 0.890Test 0.866 0.679 0.858 0.711 0.774 0.889
Dice Train 0.339 0.408 0.346 0.407 0.441 0.621Test 0.408 0.478 0.398 0.492 0.528 0.711
Youden
index
Train 0.331 0.451 0.340 0.448 0.493 0.699
Test 0.389 0.480 0.375 0.501 0.553 0.765
MCC Train 0.353 0.400 0.356 0.398 0.450 0.677Test 0.414 0.449 0.398 0.471 0.527 0.746
AUC: area under the curve. MCC: Matthews correlation coefficient. Comparison model 1: SVM.
Comparison model 2: Normalized cut loss. Comparison model 3: Size-constrained loss; Comparison
model 4: Random walker regularized loss
5.3 MRS results
The MRS results showed that the predicted infiltrated region showed significantly more aggressive
signature than the non-infiltrated region, which suggests the infiltration prediction could have signifi-
cance regarding the tumor-induced metabolic change. Specifically, choline is a marker of cellular
turnover and membrane integrity, which is correlated with tumor proliferation. NAA is a maker
of neuron structure, which may be destructed by the tumor infiltration. In previous studies, the
choline/NAA ratio was frequently used an imaging marker to indicate tumor invasiveness, which was
shown to correlate with patient outcomes. The detailed comparison of MRS data from the predicted
infiltrated ad non-inlfiltrated regions are detailed in Table 6.
Figure 4: MRS comparison of the infiltrated and non-infiltrated regions
Table 6: MRS comparison of the segmented infiltration and non-infiltration
IR Non-IR p-value
Choline Training 0.50±0.13 0.42±0.09 3.1×10
−12
Testing 0.52±0.14 0.44±0.11 4.0×10−10
Cho/NAA Training 0.65±0.35 0.48±0.20 1.4×10
−8
Testing 0.60±0.27 0.48±0.18 4.1×10−7
NAA Training 0.90±0.22 0.99±0.20 9.3×10
−8
Testing 0.95±0.24 1.03±0.21 5.9×10−6
IR: infiltration region; NAA: N-acetylaspartate
Our study has limitations. Firstly, our manual labels were delineated by human experts. Therefore,
different from the synthetic images, any analysis performed on this dataset may be biased and
subjective compared to the synthetic images. Secondly, the other weakly supervised models that
we compared with our models are not developed based on MRI. Therefore the performance may be
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affected when applied to our images. Lastly, due to the nature of tumor infiltration and ethics issue,
some infiltrated tumor may not be directed observed and measured, as some tumor regions are more
sensitive to treatment, Therefore, incorporating longitudinal MRI into the model could yield a more
accurate infiltrated tumor estimation, which we are improving in our current study.
6 Conclusions
In this paper, we presented an expectation-maximization regularized weakly supervised tumor
segmentation model based on the deep convolutional neural networks. The proposed method was
developed to segment both the core and peritumoral infiltrated tumor based on the multiparametric
MRI. This weakly supervised model was developed to tackle the challenge of obtaining the full
accurate labels for the infiltrated tumour. To effectively leverage the physiological MRI that has
higher specificity but lower resolution than structural MRI, we constructed a physiological prior
map generated from a fully connected neural network, for the iterative optimization of the CNN
segmentation model. Using the tumor burden, tumor recurrence and MRS, the model evaluation
confirms that our proposed model achieved higher accuracy than the published state-of-the-art weakly
supervised methods, using the regularizer constructed from physiological MRI.
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